Erik Fursterling

Erik Fursterling is a seasoned professional in the pharmaceutical industry, currently serving as the Head of Strategic Pricing at Viatris since November 2020, following a similar role at Mylan from March 2018 to November 2020. Erik's experience encompasses managerial positions in companies such as Orifarm Generics A/S, Orifarm A/S, and Copharma ApS, where responsibilities included area management and commercial leadership. Previous roles also include positions at A-Pharma ApS, The Raith Way, Sandoz A/S, Actavis A/S, and United Nordic Pharma A/S, showcasing a diverse background in sales, marketing, and strategic management across Nordic markets. Erik holds a graduate diploma in business studies and has a comprehensive educational foundation beginning with Vestre Skole.